The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients

被引:9
作者
Chen, Jihui [1 ]
Huang, Xiaohui [1 ]
Bu, Shuhong [1 ]
Chen, Xiaoxiao [2 ]
Zhou, Jia [1 ]
Liu, Xinzhu [1 ]
Guo, Xiaowen [1 ]
Li, Lixia [1 ]
Zhang, Jian [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Hematol Oncol, Shanghai, Peoples R China
关键词
area under the concentration-time curve; pediatric patients; pharmacokinetics; trough concentration; vancomycin; STAPHYLOCOCCUS-AUREUS INFECTIONS; HEALTH-SYSTEM PHARMACISTS; DISEASES SOCIETY; AMERICAN SOCIETY; CHILDREN; PHARMACOKINETICS; GUIDELINES;
D O I
10.1002/prp2.885
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To assess the pharmacokinetic parameters of vancomycin in Chinese critically ill pediatric patients, children treated with vancomycin, hospitalized in the intensive care unit were included. Samples to determine peak and trough serum concentrations were obtained on the third day of treatment. Half-life was significantly longer in neonates and showed a decreasing trend in infants and children. In patients aged >= 1 month, AUC(24)/MIC >= 400 was achieved in 31.8% at the dose of 40 mg/kg/d, and in 48.7% at the dose of 60 mg/kg/d with an assumed MIC of 1 mg/L. Augmented renal clearance (ARC) was present in 27.3% of children, which was associated with higher vancomycin clearance and lower AUC values. A good correlation was observed between trough concentration and AUC(24), and the trough concentration that correlated with AUC(24) of 400 were varied according to the dosage regimens, 8.42 mg/L for 6-hintervals, and 6.63 mg/L for 8-h intervals. To conclude, vancomycin trough concentration that related to the AUC(24) of 400 was much lower in critically ill children than that in adults. The dosage of 60 mg/kg/day did not enough for producing AUC(24) in the range of 400-600 mg h/L in critically ill children, especially in those with ARC.
引用
收藏
页数:9
相关论文
共 31 条
[11]  
Jorgensen S., 2021, CLIN INFECT DIS, V72, P1502, DOI [10.1093/cid/ciaa1743, DOI 10.1093/CID/CIAA1743]
[12]   Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children [J].
Liu, Catherine ;
Bayer, Arnold ;
Cosgrove, Sara E. ;
Daum, Robert S. ;
Fridkin, Scott K. ;
Gorwitz, Rachel J. ;
Kaplan, Sheldon L. ;
Karchmer, Adolf W. ;
Levine, Donald P. ;
Murray, Barbara E. ;
Rybak, Michael J. ;
Talan, David A. ;
Chambers, Henry F. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) :E18-E55
[13]   Population pharmacokinetics of vancomycin in Chinese pediatric patients [J].
Liu, Taotao ;
Deng, Chenhui ;
Cheng, Daohai ;
Zhou, Tianyan ;
Lu, Hua ;
Wei, Wenxing ;
Lu, Wei .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (06) :509-516
[14]   Retrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients [J].
Liu, Yan ;
Yin, You ;
Liu, Xin-Zhu ;
Yao, Hui-Juan ;
Li, Li-Xia ;
Chen, Ji-Hui ;
Chen, Ting ;
Lu, Xiao-Tong ;
Bu, Shu-Hong ;
Zhang, Jian .
PHARMACOLOGY, 2015, 95 (5-6) :279-284
[15]   Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children [J].
Lv, Chun-Le ;
Lu, Jie-Jiu ;
Chen, Ming ;
Zhang, Ren ;
Li, Qiao-Chuan ;
Chen, Yi-Yu ;
Liu, Tao-Tao .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) :1278-1287
[16]   Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center [J].
Meng, Lina ;
Wong, Tiffany ;
Huang, Sharon ;
Mui, Emily ;
Nguyen, Vinhkhoa ;
Espinosa, Gabriela ;
Desai, Janjri ;
Holubar, Marisa ;
Deresinski, Stan .
PHARMACOTHERAPY, 2019, 39 (04) :433-442
[17]  
Outcomes IG. (KDIGO) CKD work group. KDIGO, 2012, KIDNEY INT SUPPL, V2013, p1 150
[18]   Innovative approaches to optimizing the delivery of vancomycin in individual patients [J].
Pai, Manjunath P. ;
Neely, Michael ;
Rodvold, Keith A. ;
Lodise, Thomas P. .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 77 :50-57
[19]   Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis [J].
Ray, Abhisekh Sinha ;
Haikal, Ammar ;
Hammoud, Kassem A. ;
Yu, Alan S. L. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (12) :2132-2140
[20]   Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists [J].
Rybak, Michael J. ;
Le, Jennifer ;
Lodise, Thomas P. ;
Levine, Donald P. ;
Bradley, John S. ;
Liu, Catherine ;
Mueller, Bruce A. ;
Pai, Manjunath P. ;
Wong-Beringer, Annie ;
Rotschafer, John C. ;
Rodvold, Keith A. ;
Maples, Holly D. ;
Lomaestro, Benjamin .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) :1361-1364